High Risk Coronary Intervention Articles & Analysis
4 news found
PMD announced it will present its first-in-human results for the ModulHeartTM in the following session during the American Heart Association (AHA) meeting held November 5–7, 2022 at the McCormick Place Convention Center in Chicago, IL: Four patients had ModulHeartTM deployed to provide circulatory support while undergoing high-risk percutaneous ...
Four patients had ModulHeartTM deployed to provide circulatory support while undergoing high-risk percutaneous coronary intervention procedures. All patients experienced improvements in cardiac and kidney function. ...
Four patients had ModulHeart deployed to provide circulatory support while undergoing high-risk percutaneous coronary intervention (PCI) procedures. All patients experienced improvements in cardiac and kidney function. ...
While we were working, we determined it would be a shorter regulatory path to have a catheter temporary aortic stent pump which could relieve the patient of excess fluids, help them get through a high risk Percutaneous Coronary intervention (PCI) procedure, maybe help them recover from cardiogenic shock and, most needed to help ...